New investment quotas are quickly approved and QDII products are ready for sale.

Recently, with the approval from the State Administration of Foreign Exchange for a new batch of QDII investment quotas, many public fund institutions have quickly taken action to allocate their popular QDII products. From March 31st to April 1st, a variety of popular QDII products such as the S&P 500, NASDAQ 100, NASDAQ Biotechnology, US Dollar Bonds, and Hang Seng Technology have successively announced an increase in subscription limits. Some of the newly approved QDII quotas have been promptly distributed to investors for subscription.